The incidence and management of tolerance in intrathecal baclofen therapy. - Wikidata - awgldk - TriplyDB

The incidence and management of tolerance in intrathecal baclofen therapy.

The incidence and management of tolerance in intrathecal baclofen therapy.

http://www.wikidata.org/entity/Q34971740

about

Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review.Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.Combined selective dorsal rhizotomy and scoliosis correction procedure in patients with cerebral palsy.Best Practices for Intrathecal Baclofen Therapy: Troubleshooting.Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injury Infectious Complications of Intrathecal Drug Administration Systems for Spasticity and Chronic Pain: 145 Patients From a Tertiary Care Center.Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats.Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.Rate of complications among the recipients of intrathecal baclofen pump in Japan: a multicenter study.Patient experiences with intrathecal baclofen as a treatment for spasticity - a pilot study.Oral baclofen reduces visceral pain-related pseudo-affective responses to colorectal distension in rats: relation between plasma exposure and efficacy.Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.Creating a new problem: The use of baclofen in the management of alcohol use disorder.

P2860

Q30039702-F8676A2A-6858-41B8-A63F-1D367DAEC030 Q30396983-BD81AB8D-5C58-47A0-AEE4-63DD61C09A75 Q35013253-F2999D71-F595-4781-B579-82CFB94FE026 Q35923194-5DF209F4-80DC-4EA3-9E61-3278F59D5587 Q35956109-CEF279C6-59D6-416C-9759-D09F720A96F1 Q37710249-6F502D40-11CF-42C3-A0B5-20836238BB7B Q38121880-1C9F4FF9-EAE3-4DF3-88DF-2086027B3A0D Q38569757-D4BF467E-97FD-4288-8F54-9D22A072EF77 Q38902185-98465E3F-6747-498E-8272-C79EDC45671B Q41150048-0FC6E54C-18DA-4B29-8A8F-245D497247D4 Q41549743-41AA0DC9-AB99-496F-A055-86A1DCE59C45 Q41958257-1D0A1F8B-67F1-4B13-AF1B-255280FD52D6 Q42548830-30C8589A-5E55-46BA-B4E8-232C9B5188AA Q43784278-701131D0-C42F-4CCB-90E0-BFBAD609476C Q48092385-EE43820F-359F-4D5A-B6A3-64E7E784C217 Q51485931-3415BB47-9397-4E0D-9005-2E7B3157223C Q51658623-C7731881-855F-4F9E-AF4C-8BDE2C8FD23E Q52307317-58D42594-4DD6-4ED1-8293-125BD7F3BBCE

P2860

The incidence and management of tolerance in intrathecal baclofen therapy.

http://www.wikidata.org/entity/Q34971740

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The incidence and management of tolerance in intrathecal baclofen therapy.

@ast

The incidence and management of tolerance in intrathecal baclofen therapy.

@en

The incidence and management of tolerance in intrathecal baclofen therapy.

@nl

type

label

The incidence and management of tolerance in intrathecal baclofen therapy.

@ast

The incidence and management of tolerance in intrathecal baclofen therapy.

@en

The incidence and management of tolerance in intrathecal baclofen therapy.

@nl

prefLabel

The incidence and management of tolerance in intrathecal baclofen therapy.

@ast

The incidence and management of tolerance in intrathecal baclofen therapy.

@en

The incidence and management of tolerance in intrathecal baclofen therapy.

@nl

P1433

Q34971740-89CDEDA6-388F-4BB3-967D-BEF9391664F8

P1476

Q34971740-8D6555EB-7F49-4C5F-9990-747AC306C997

P2093

Q34971740-0251258C-2AA2-491A-B280-83860416BEC3

Q34971740-38A4EFA9-125A-483A-8056-4CC6CBB8E114

Q34971740-4FB54A5B-A919-4425-AF5B-3992CBB2A108

Q34971740-65710C41-8EA2-4879-8C35-951F126955B8

P2860

Q34971740-068AB7C9-E4B0-4409-B62D-8A78BB866389

Q34971740-0A1BD980-78FB-4156-AB69-C4C81116109B

Q34971740-1910E067-CA75-4A64-A53F-953DA7439FC5

Q34971740-59EBC080-F8D3-47AE-BD82-18916C3BB6CF

Q34971740-79628319-5FF9-4CE6-8403-7EAE29A9B79E

Q34971740-93B915B8-B09D-40DB-AFC1-38550A0539B8

Q34971740-B4593182-4F14-4258-8DD5-8330658546E5

Q34971740-DB54142C-135F-4AA9-9361-4E06F4D7192C

Q34971740-E3B52542-47F1-4D37-8A33-36A99D12F392

Q34971740-ECADC0BC-A6E0-4BF6-8BEB-FF6368B69B54

P2888

Q34971740-036FFBD1-3CFA-46D1-9B68-5FEA75C668EF

P304

Q34971740-D3011B63-EE3B-43B6-BA12-4ED7DB82DE77

P31

Q34971740-F778E8B9-8918-4C86-B05F-70A9C1C04D14

P356

Q34971740-BFD79185-B4E1-4DDA-9A03-434F4DC2DBB7

P433

Q34971740-9C6C03B1-29B1-469D-98C7-BFF273133A09

P478

Q34971740-4B59B412-079D-46A2-B75A-33E2A1E9CC85

P577

Q34971740-1756708B-0EB9-46D1-8D9A-10A6F6814004

P5875

Q34971740-FF790F9C-9A93-475E-8A12-ADCAE1D7BF2F

P6179

Q34971740-F1E3B0DE-A047-4CAE-972C-5F9342E6E3EE

P698

Q34971740-9CFE094E-E02F-4E97-A3B4-C9B6263415DC

P356

P1433

P1476

The incidence and management of tolerance in intrathecal baclofen therapy.

@en

P2093

C Kliphuis

http://www.w3.org/2001/XMLSchema#string

H W Heetla

http://www.w3.org/2001/XMLSchema#string

M J Staal

http://www.w3.org/2001/XMLSchema#string

T van Laar

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term spinal analgesic delivery: a review of the preclinical and clinical literature.

Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen.

Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis.

Delirium associated with baclofen withdrawal: a review of common presentations and management strategies.

Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome.

Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance--a case report and review of literature.

Device-related complications of long-term intrathecal drug therapy via implanted pumps.

Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.

Efficacy of intrathecal morphine in the treatment of baclofen tolerance in a patient on intrathecal baclofen therapy (ITB).

Intrathecal baclofen withdrawal: emergent recognition and management.

P2888

P304

751-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SC.2009.34

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24245523

http://www.w3.org/2001/XMLSchema#string

P6179

1009684075

http://www.w3.org/2001/XMLSchema#string

P698

19333246

http://www.w3.org/2001/XMLSchema#string